Comprehensive insulin receptor phosphorylation dynamics profiled by mass spectrometry.

Zhongping Liao1, Chen Zhang1, Liyun Ding1

  • 1Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.

The FEBS Journal
|November 26, 2021
PubMed
Summary

This study comprehensively mapped insulin receptor (IR) phosphorylation sites, revealing diverse signaling dynamics with different agonists. Findings impact understanding IR signaling and developing new therapeutic agents.